#ASAPbio is currently discussing the future of #science publication! #scicomm #starstuddedcast

Just in case you weren’t aware, ASAPbio is currently underway and is likely going to influence the future of science publication!!

Accelerating Science and Publication in Biology (ASAPbio) will be an interactive meeting to discuss the use of preprints in biology held on February 16-17, 2016. The meeting will be streamed online, and we welcome participation from all interested parties through this website and on Twitter (#ASAPbio).

For background on the issues facing science publication, especially in biomedical science and biology, check out this primer from Nature last week (Does it take too long to publish research?). We here at CauseScience think that the answer to that title is a resounding YES!! One option that ASAPbio is considering are preprints – commonly used in other science fields. Nature this week featured another article related to ASAPbio about preprints (Biologists urged to hug a preprint).

For up to date info on the conference, check out the twitter hashtag #ASAPbio, which thus far has included tweets from well-known scientists, and fun pictures of former NIH directors and Nobel Laureates!! Or just visit the ASAPbio website!!

Definitely exciting to see people discussing the problems of science publication, but more importantly, discussing potential solutions!!

Advertisements

Girl Power! HHMI selects female biochemist Erin O’Shea as next President

Who run the (world) HHMI? Girls!

The Howard Hughes Medical Institute (HHMI) has named Erin O’Shea its sixth president, effective September 1, 2016. O’Shea currently serves as HHMI’s chief scientific officer, a position she has held since 2013.

O’Shea will succeed Robert Tjian, HHMI’s president since 2009. Tjian announced last year that he would step down and return to the University of California, Berkeley.

Kurt Schmoke, chairman of the HHMI Trustees and head of the committee that conducted the search, commented: “We’re delighted to welcome Dr. O’Shea into her new leadership role as the next president of HHMI. She is not only a distinguished scientist but also a leader committed to advancing HHMI’s unique role in the research community. Going forward, Dr. O’Shea will build on her accomplishments at HHMI, as well as the success of outgoing HHMI President Bob Tjian. We look forward to this exciting new chapter.”

O’Shea, 50, is a leader in the fields of gene regulation, signal transduction, and systems biology. An HHMI investigator since 2000, she has served on the faculty of Harvard University and the University of California, San Francisco. She is a member of the National Academy of Sciences and the American Academy of Arts and Sciences. O’Shea received her undergraduate degree in biochemistry from Smith College and her PhD degree in chemistry from the Massachusetts Institute of Technology.

Since joining HHMI in 2013, O’Shea has worked to enhance diversity in science, and to expand the institute’s support for researchers across career stages and its collaborations with other funders, including the Bill & Melinda Gates Foundation, the Simons Foundation, and the Wellcome Trust.

“HHMI pursues high-risk, high-reward science that can change the future,” said O’Shea. “I’m honored to have the opportunity to lead the institute, and I look forward to the important work ahead.”